plans to phase out any levothyroxine products that don't have an approved NDA

The FDA is proceeding with plans to phase out any levothyroxine products that don't have an approved NDA.

Companies that don't submit an NDA by August 14th will have to stop making it...and companies still awaiting approval will be required to reduce production every 3 months until approved.

So far Unithroid and Levoxyl are the only approved products.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote